# Remission Induction in Very Early Rheumatoid Arthritis

> **NCT00523692** · PHASE4 · UNKNOWN · sponsor: **University Hospital Birmingham** · enrollment: 20 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Etanercept, methotrexate and depomedrone
- **DRUG:** depemedrone

## Key facts

- **NCT ID:** NCT00523692
- **Lead sponsor:** University Hospital Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2007-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523692, "Remission Induction in Very Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00523692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*